Ä¢¹½ÊÓƵ

MITSUBISHI CHEMICAL GROUP
MITSUBISHI CHEMICAL GROUP

Marketing Authorization Application of Pertussis, Diphtheria, Tetanus, Inactivated Polio and Hib Combined Vaccine (BK1310/MT-2355)

April 11, 2022

Mitsubishi Tanabe Pharma Corporation, a member of the Mitsubishi Chemical Holdings Group, has announced the following press release.

¡öMitsubishi Tanabe Pharma¡¡Press Release
Marketing Authorization Application of Pertussis, Diphtheria, Tetanus, Inactivated Polio and Hib Combined Vaccine (BK1310/MT-2355)

 

?Information is current as of the date of issue of the individual press release. Please be advised that information may be outdated after that point.

Back to top